로딩 중…
StockDiggingStockDigging

Kukje Pharma Co., Ltd.

002720· KOSPI
₩3,405-2.16%
2026-06-19

Price Chart

Kukje Pharma Co., Ltd.-28.62%

Financials

Investment Metrics(as of 2026-06-19)

MetricValue
Size
Market Cap72.05B KRW
Revenue177.97B KRW
Net Income-440.7M KRW
Total Assets178.93B KRW
Net Assets98.50B KRW
Employees256
Value
P/B0.73x
P/S0.40x
FCF Yield3.08%
Profitability
ROE-0.45%
ROA-0.25%
Op. Margin-1.05%
Revenue Growth5.96%
Earnings Growth15.69%
Financial Health
Debt Ratio181.64%
Total Debt30.00B KRW
FCF2.22B KRW
Cash9.08B KRW
Current Ratio1.09x
Dividend
Div. Yield0.86%
Div. Growth0.00%
Performance
1Y Return-28.62%
1M Return-14.88%
From 52W High-37.75%
1Y MDD-38.81%
Trading
Volume51,267 shares
Foreign Own.4.16%
Per Share
EPS283 KRW
BPS4,655 KRW

Company Info

CEO 남태훈
Employees 256
Founded 1959
HQ 경기도 성남시, KR

Kukje Pharma, established in 1959, is a specialized pharmaceutical manufacturing and sales company, listed on the securities market in 1975, and founded its subsidiary Kukje Care in 2011. It handles both specialized pharmaceuticals, like QRalone Eye Drops, and over-the-counter drugs, supplying products nationwide from its Seongnam headquarters and manufacturing/research facilities in Ansan. The company is actively researching 2 new drugs and 3 modified new drugs, aiming for new drug development and increased sales by developing anti-inflammatory treatments such as indole carboxamide derivatives. Kukje Pharma is headquartered in Seongnam-si, Gyeonggi-do.